$0.604500
-0.02-3.74%
At close: -
Comments
Loading...
CEL-SCI (AMEX:CVM) Stock Quotes, Forecast and News Summary
CEL-SCI Stock (AMEX: CVM) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy CEL-SCI (CVM) stock?
You can purchase shares of CEL-SCI (AMEX:CVM) through any online brokerage.
Who are CEL-SCI (CVM) competitors?
Other companies in CEL-SCI’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Fortress Biotech (NASDAQ:FBIO), OncoCyte (NASDAQ:OCX), Gain Therapeutics (NASDAQ:GANX) and Intensity Therapeutics (NASDAQ:INTS).
What is the forecast, or price target, for CEL-SCI (CVM) stock?
CEL-SCI has a consensus price target of $13.00.
What is the current price for CEL-SCI (CVM)?
The stock price for CEL-SCI (AMEX: CVM) is $0.6076 last updated November 21, 2024 at 5:36 PM EST.
Does CEL-SCI (CVM) pay a dividend?
There are no upcoming dividends for CEL-SCI.
When is CEL-SCI (AMEX:CVM) reporting earnings?
CEL-SCI’s Q1 earnings are confirmed for Wednesday, February 12, 2025.
Is CEL-SCI (CVM) going to split?
There is no upcoming split for CEL-SCI.
What sector and industry does CEL-SCI (CVM) operate in?
CEL-SCI is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.